Uvette Lou

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression<i>in vitro</i>and<i>in vivo</i>

Anna Goc, Belal Al‐Husein, Katerina Katsanevas et al. · Oncotarget · 2014 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17

The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm

Amna Zafar, Zsófia D. Drobni, Ramya Mosarla et al. · JACC CardioOncology · 2021 · 73 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm

Amna Zafar, Zsófia D. Drobni, Matthew Lei et al. · PLoS ONE · 2022 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

Matthew Lei, Mark N Sorial, Uvette Lou et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2024 · 17 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma

Matthew Lei, Erica Tavares, Evan Buzgo et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2022 · 14 citations

Medicine, Internal Medicine, Oncology +9